Navigation Links
Galderma Announces Interim Data Relating to Sequential Treatment Regimen of Clobex(R) Spray Followed by Vectical(TM) Ointment in Managing Plaque Psoriasis
Date:3/6/2009

f Dermatology, Mount Sinai School of Medicine, New York, and lead author of the study. "However, it is also exciting to have interim results that indicate the use of Clobex Spray followed by Vectical Ointment fits well within accepted and common psoriasis treatment regimens."

"These study results reinforce our commitment to bringing safe and effective therapies to the millions of patients that suffer from psoriasis," said Ron Gottschalk, M.D., Medical Director, Galderma Laboratories, L.P. "We look forward to reporting the final results of this study, which are expected to be published early next year. We believe this study will confirm that Vectical Ointment can help maintain, for at least 8 weeks, much of the gains seen when a high potency corticosteroid is used to initially treat moderate to severe plaque psoriasis."

Important Safety Information About Clobex(R) (clobetasol propionate) Spray 0.05%

Clobetasol propionate has been shown to suppress the HPA axis at the lowest doses tested. In controlled clinical trials, the following adverse reactions have been reported: burning, pruritus, dryness, pain, hyperpigmentation around resolving plaque, irritation and atrophy. Clobex(R) (clobetasol propionate) Spray, Lotion and Shampoo, 0.05% are not recommended for use on anyone younger than 18 years of age. Treatment should be limited to four consecutive weeks for psoriasis, and to two consecutive weeks for other SRDs. The total dosage for Spray should not exceed 50 g (59 mL or 2 fl oz) per week, and for Lotion and Shampoo should not exceed 50 g (50 mL or 1.75 fl oz) per week. Patients should use Clobex(R) (clobetasol propionate) Spray, Lotion or Shampoo, 0.05%, only for the minimum period necessary to achieve desired results. It should not be used on the face, groin, or axillae.

Important Safety Information About Vectical(TM) (calcitriol) Ointment 3mcg/g

Vectical(TM) Oin
'/>"/>

SOURCE Galderma Laboratories, L.P.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Foamix and Galderma to Develop Medicated Foam for Certain Skin Diseases
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... IRVINE, Calif. , Oct 22, 2014 ... Irvine, California , announced the receipt ... Small Business Innovation Research award (SBIR) from the National Institute of ... will fund the development of a Pan-HIV Protein Microarray ... the HIV-1 and HIV-2 subtypes and aid in the ...
(Date:10/22/2014)... 22, 2014 Moms are ready to live ... themselves and their kids, according to the results of ... Fitness Go Mobile for Moms, the latest installment in ... number 1 pregnancy and parenting web and mobile destination ... of moms surveyed say they can,t think of a ...
(Date:10/22/2014)... 22, 2014 A new report ... (Product type, Form, End user, Application and Geography) - ... Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020", ... Based on key trends tracked, it is anticipated that ... billion by 2020, registering a CAGR of 6.2% from ...
Breaking Medicine Technology:Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip 2BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 2BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 3BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 4Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 4
... , REDWOOD CITY, ... of its relationship and the signing of its second agreement ... generic drug manufacturer. The new agreement covers three undisclosed ... on January 7. , Under the new agreement, Teva will ...
... ... global financial crisis, government pressure, changing market dynamics for an industry ... drive up the effective tax rate for the ... today by PricewaterhouseCoopers entitled Pharma 2020: Taxing times ahead - ...
Cached Medicine Technology:Codexis Expands Collaboration with Teva 2Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 2Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 3Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 4Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 5
(Date:10/22/2014)... Oct. 21, 2014 (HealthDay News) -- Measures taken by ... in Ebola-ravaged Liberia may have limited the spread of ... report. The Firestone Natural Rubber Co. provides health ... residents of nearby densely populated communities. Between Aug. ... suspected Ebola cases among those 80,000 people. That incidence ...
(Date:10/22/2014)... By Dennis Thompson HealthDay ... freelance cameraman who was diagnosed with Ebola while working for ... system and can leave the special isolation unit at Nebraska Medical ... two weeks, the hospital said Tuesday. A blood test confirmed ... Ashoka Mukpo, 33, can head home to Providence, R.I., NBC ...
(Date:10/20/2014)... Orlando, Florida (PRWEB) October 20, 2014 ... fired-up former Gov. Charlie Crist made a brief fundraising ...  in Orlando on Thursday. , Fresh from a debate ... refused to take the stage for the first seven ... podium, the former governor described the incident in one ...
(Date:10/20/2014)... Wakefield, MA (PRWEB) October 20, 2014 ... be sponsoring a booth at the American Foundation for ... October 25th. The AFSP is a not-for-profit organization that ... year. Net proceeds from these events are used to ... research, but education and personal relationships as well. ...
(Date:10/20/2014)... Women’s health specialist, Dr. Amber Murphy, MD, Ob/Gyn ... Inc., A Division of MaternOhio Clinical Associates, Inc., who ... patients annually. Dr. Murphy will provide a full range ... women’s life. She is accepting new patients at two ... , Dr. Murphy offers a wide variety of services ...
Breaking Medicine News(10 mins):Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 2Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 3
... scientists, led by Tracy Hussell at Imperial College, London, ... vulnerable to infection with pneumonia-causing bacteria. Components of these ... lung. These signals result in the recruitment of other ... bugs. But in post-flu mice, these receptors were not ...
... , Fighting fat bloom can mean a prettier ... Food Chemistry , Chemists in England and the Netherlands ... Valentines Day chocolates, and other goodies, looking fresher and tastier. ... the outside of chocolate, is scheduled for the March 12 ...
... Viral Load Testing to the U.S. ... ... Siemens Healthcare, (http://www.siemens.com/diagnostics ) announced today that its VERSANT(TM) 440,Molecular ... Drug,Administration (FDA) for use with the VERSANT HCV RNA 3.0 assay ...
... stem works, linguist says , , MONDAY, Feb. 18 (HealthDay ... the development of the brain more than previously thought, ... stem, but it,s tuned differently depending on what sounds ... sounds of his or her mother tongue," Jackson T. ...
... on cocaine addiction - and attempts to block its ... reabsorb the brain,s "reward" chemical once its signal is ... recycling job, it leaves the feel-good chemical around to ... conducted at the U.S. Department of Energy,s Brookhaven National ...
... International Limited (NYSE: MR ), a leading developer, ... that it will,report its financial results for the fourth ... U.S. market closes on March 5, 2008. Mindray,s,management will ... March 5,2008 U.S. Eastern Time (9:00 AM on March ...
Cached Medicine News:Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 2Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 3Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 4Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 5Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 6Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 7Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 8Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 9Health News:Siemens Receives FDA Approval for the VERSANT 440 Molecular System 2Health News:Siemens Receives FDA Approval for the VERSANT 440 Molecular System 3Health News:Pitch Patterns Play Greater Role in Speech Perception 2Health News:Cocaine's effects on brain metabolism may contribute to abuse 2Health News:Mindray to Report Fourth Quarter and Fiscal Year 2007 Financial Results on March 5, 2008 2
MONOJECT Red/Yellow Mottled Stopper...
Inquire...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
BD Vacutainer® Fluoride Tubes - Plastic...
Medicine Products: